Oxford Covid-19 trial will look at interim Phase III data after 53 infections - investigator
The Oxford Vaccine Group’s director Andrew Pollard said there were “lots of cases” of infections in its Phase III trial in Britain, Brazil and South Africa
The Oxford Vaccine Group’s director Andrew Pollard said there were “lots of cases” of infections in its Phase III trial in Britain, Brazil and South Africa